Groowe Groowe / Newsroom / NVO
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

NVO News

Novo-Nordisk A/S

Global Times: A target of seeking progress while maintaining stability, being proactive and pragmatic

prnewswire.com
LUV XPEV LI NIO PLUG SEDG ENPH DQ JKS BE FCEL RUN FSLR BABA JD PDD BYDDY TSLA GM F RIVN LCID NVDA AMD INTC MU AMAT LRCX KLAC ASML SMCI MSFT GOOGL AMZN IBM ORCL CRM ADBE PYPL COIN UPST SOFI AXP V MA GS JPM MS BAC WFC CMCSA VZ T NFLX DIS CMG MCD SBUX YUM PEP KO PG JNJ PFE MRK BMY LLY ABBV GILD AMGN BIIB REGN VRTX MRNA BNTX AZN NVO SNY XOM CVX SHEL BZUN VIPS QCOM MRVL NXPI ON ADI MCHP AVGO QGEN ILMN EXAS MDLZ KDP GIS KHC CL EL NKE UA LULU CPRI PVH M TJX ROST BBY HD LOW COST WMT TGT KR LVS MGM WYNN CCL RCL NCLH DAL UAL AAL BA GD LMT RTX GE HON CAT DE MMM DOW DD ECL IFF ADM CF MOS NTR BHP RIO VALE AA FCX STLD NUE CFG KEY USB PNC BBT STI BBVA HSBC SCHW RJF SYF CINF

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Novo Nordisk A/S (NVO) And Encourages Shareholders to Reach Out

accessnewswire.com
NVO

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novo Nordisk A/S - NVO

accessnewswire.com
NVO

Obesity Care Week 2026 Concludes with Global Momentum for Advancing Care

prnewswire.com
LLY AMGN REGN NVO BSX

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novo Nordisk A/S - NVO

prnewswire.com
NVO

Bronstein, Gewirtz & Grossman, LLC Encourages Novo Nordisk A/S (NVO) Stockholders to Inquire about Securities Investigation

accessnewswire.com
NVO

GLP-1 Receptor Agonist (Trulicity, Wegovy, Ozempic, Mounjaro) Market Trends Analysis Report 2026

globenewswire.com
LLY NVO

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novo Nordisk A/S - NVO

accessnewswire.com
NVO

Global Orphan Drugs Market is Anticipated to Cross USD 350 Billion by 2032 | DelveInsight

prnewswire.com
BIIB IONS ALNY AZN GILD JNJ BMRN VRTX ASTL PFE NVO REGN

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Novo Nordisk A/S (NVO) and Encourages Investors to Learn More About the Investigation

accessnewswire.com
NVO